| Mesoporous systems for poorly soluble drugs W Xu, J Riikonen, VP Lehto International journal of pharmaceutics 453 (1), 181-197, 2013 | 252 | 2013 |
| In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ... Acta biomaterialia 6 (7), 2721-2731, 2010 | 198 | 2010 |
| Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ... Chemical research in toxicology 20 (12), 1913-1918, 2007 | 175 | 2007 |
| In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles M Kilpeläinen, J Riikonen, MA Vlasova, A Huotari, VP Lehto, J Salonen, ... Journal of Controlled Release 137 (2), 166-170, 2009 | 146 | 2009 |
| Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles T Limnell, J Riikonen, J Salonen, AM Kaukonen, L Laitinen, J Hirvonen, ... International journal of pharmaceutics 343 (1-2), 141-147, 2007 | 136 | 2007 |
| Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations M Kaasalainen, E Mäkilä, J Riikonen, M Kovalainen, K Järvinen, ... International journal of pharmaceutics 431 (1-2), 230-236, 2012 | 101 | 2012 |
| Surface chemistry, reactivity, and pore structure of porous silicon oxidized by various methods J Riikonen, M Salomaki, J van Wonderen, M Kemell, W Xu, O Korhonen, ... Langmuir 28 (28), 10573-10583, 2012 | 97 | 2012 |
| Utilising thermoporometry to obtain new insights into nanostructured materials: review part 1 J Riikonen, J Salonen, VP Lehto Journal of thermal analysis and calorimetry 105 (3), 811-821, 2011 | 96 | 2011 |
| Determination of the physical state of drug molecules in mesoporous silicon with different surface chemistries J Riikonen, E Makila, J Salonen, VP Lehto Langmuir 25 (11), 6137-6142, 2009 | 91 | 2009 |
| Novel delivery systems for improving the clinical use of peptides M Kovalainen, J Mönkäre, J Riikonen, U Pesonen, M Vlasova, J Salonen, ... Pharmacological reviews 67 (3), 541-561, 2015 | 82 | 2015 |
| Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery M Kilpeläinen, J Mönkäre, MA Vlasova, J Riikonen, VP Lehto, J Salonen, ... European Journal of Pharmaceutics and Biopharmaceutics 77 (1), 20-25, 2011 | 76 | 2011 |
| Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration S Näkki, J Rytkönen, T Nissinen, C Florea, J Riikonen, P Ek, H Zhang, ... Acta biomaterialia 13, 207-215, 2015 | 73 | 2015 |
| Development of porous silicon nanocarriers for parenteral peptide delivery M Kovalainen, J Monkare, M Kaasalainen, J Riikonen, VP Lehto, ... Molecular Pharmaceutics 10 (1), 353-359, 2013 | 65 | 2013 |
| Mesoporous systems for poorly soluble drugs–recent trends J Riikonen, W Xu, VP Lehto International journal of pharmaceutics 536 (1), 178-186, 2018 | 64 | 2018 |
| Intraorally fast-dissolving particles of a poorly soluble drug: Preparation and in vitro characterization R Laitinen, E Suihko, K Toukola, M Björkqvist, J Riikonen, VP Lehto, ... European journal of pharmaceutics and biopharmaceutics 71 (2), 271-281, 2009 | 59 | 2009 |
| Amine surface modifications and fluorescent labeling of thermally stabilized mesoporous silicon nanoparticles W Xu, J Riikonen, T Nissinen, M Suvanto, K Rilla, B Li, Q Wang, F Deng, ... The Journal of Physical Chemistry C 116 (42), 22307-22314, 2012 | 54 | 2012 |
| Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib J Riikonen, A Correia, M Kovalainen, S Näkki, M Lehtonen, J Leppänen, ... Biomaterials 52, 44-55, 2015 | 47 | 2015 |
| Synthesis and characterization of Al2O3 nanoparticles by flame spray pyrolysis (FSP)—Role of Fe ions in the precursor LD Hafshejani, S Tangsir, H Koponen, J Riikonen, T Karhunen, U Tapper, ... Powder technology 298, 42-49, 2016 | 40 | 2016 |
| Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation R Laitinen, E Suihko, M Bjorkqvist, J Riikonen, VP Lehto, K Jarvinen, ... Drug development and industrial pharmacy 36 (5), 601-613, 2010 | 40 | 2010 |
| Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery E Korhonen, S Rönkkö, S Hillebrand, J Riikonen, W Xu, K Järvinen, ... European Journal of Pharmaceutics and Biopharmaceutics 100, 1-8, 2016 | 39 | 2016 |
